In contrast, CRISPR screening combined with a PDX model identified both previously reported AML targets and two novel genes related to AML cell survival, SLC5A3 and MARCH5. Promisingly, knock-out of SLC5A3 and MARCH5 significantly inhibits proliferation of AML cells. Here, MARCHF5 is linked to acute myeloid leukemia.